These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6271541)

  • 1. Characterization of cholecystokinin receptors on rat pancreatic membranes.
    Steigerwalt RW; Williams JA
    Endocrinology; 1981 Nov; 109(5):1746-53. PubMed ID: 6271541
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes in the rat is associated with a reversible postreceptor defect in cholecystokinin action.
    Otsuki M; Goldfine ID; Williams JA
    Gastroenterology; 1984 Oct; 87(4):882-7. PubMed ID: 6205933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic CCK receptors: characterization of covalently labeled subunits.
    Sakamoto C; Goldfine ID; Williams JA
    Biochem Biophys Res Commun; 1984 Jan; 118(2):623-8. PubMed ID: 6322755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific photoaffinity crosslinking of [125I]cholecystokinin to pancreatic plasma membranes. Evidence for a disulfide-linked Mr 76 000 peptide in cholecystokinin receptors.
    Svoboda M; Lambert M; Furnelle J; Christophe J
    Regul Pept; 1982 Aug; 4(3):163-72. PubMed ID: 6291100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reduced pancreatic protein secretion in response to cholecystokinin (CCK) in the obese Zucker rat correlates with a reduced receptor capacity for CCK.
    Praissman M; Izzo RS
    Endocrinology; 1986 Aug; 119(2):546-53. PubMed ID: 3015550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity.
    Makovec F; Bani M; Chisté R; Revel L; Rovati LC; Rovati LA
    Arzneimittelforschung; 1986; 36(1):98-102. PubMed ID: 3006713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CCK receptor on pancreatic plasma membranes: binding characteristics and covalent cross-linking.
    Sakamoto C; Williams JA; Wong KY; Goldfine ID
    FEBS Lett; 1983 Jan; 151(1):63-6. PubMed ID: 6297990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors.
    Chang RS; Lotti VJ; Chen TB; Kunkel KA
    Mol Pharmacol; 1986 Sep; 30(3):212-7. PubMed ID: 3018478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of somatostatin to guinea-pig pancreatic membranes: regulation by ions.
    Taparel D; Estève JP; Susini C; Vaysse N; Balas D; Berthon G; Wunsch E; Ribet A
    Biochem Biophys Res Commun; 1983 Sep; 115(3):827-33. PubMed ID: 6138038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of a fully active biotinylated probe of cholecystokinin.
    Izzo RS; Pellecchia C; Weinstein MI; Massimillo AJ
    Prep Biochem; 1990; 20(3-4):205-17. PubMed ID: 2287607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abnormal cholecystokinin-acinar function coupling in atrophied pancreatic acini from rats fed ethanol and a high-fat diet].
    Tsukamoto H; Otsuki M; Baba S; Mizoi Y
    Arukoru Kenkyuto Yakubutsu Ison; 1988 Dec; 23(4):332-50. PubMed ID: 2472128
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and characterization of receptors for secretagogues on pancreatic acinar cells.
    Jensen RT; Gardner JD
    Fed Proc; 1981 Aug; 40(10):2486-96. PubMed ID: 6266878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin-dopamine receptor interactions as studied with cholecystokinin receptor antagonists.
    Murphy RB
    Prog Clin Biol Res; 1985; 192():105-13. PubMed ID: 3001746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of interactions between CCK-33 and CCK receptors in isolated dispersed pancreatic acini.
    Hosotani R; Chowdhury P; Doi R; Rayford PL
    J Cell Physiol; 1992 Dec; 153(3):523-7. PubMed ID: 1280279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin receptors in the brain: characterization and distribution.
    Saito A; Sankaran H; Goldfine ID; Williams JA
    Science; 1980 Jun; 208(4448):1155-6. PubMed ID: 6246582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for interactions between striatal cholecystokinin and glutamate receptors. CCK-8 in vitro produces a marked downregulation of 3H-glutamate binding sites in striatal membranes.
    Fuxe K; Agnati LF; Celani MF
    Acta Physiol Scand; 1983 May; 118(1):75-7. PubMed ID: 6312747
    [No Abstract]   [Full Text] [Related]  

  • 17. Assay for the cholecystokinin receptor on pancreatic acini.
    Jensen RT; Gardner JD
    Methods Enzymol; 1985; 109():64-9. PubMed ID: 2985933
    [No Abstract]   [Full Text] [Related]  

  • 18. Receptors for cholecystokinin and insulin in isolated pancreatic acini: hormonal control of secretion and metabolism.
    Williams JA; Sankaran H; Korc M; Goldfine ID
    Fed Proc; 1981 Aug; 40(10):2497-502. PubMed ID: 6266879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface properties of pancreatic acinar cells: relationship to secretagogue action.
    Jamieson JD; Hull BE; Galardy RE; Maylié-Pfenninger MF
    Symp Soc Exp Biol; 1979; 33():145-60. PubMed ID: 230605
    [No Abstract]   [Full Text] [Related]  

  • 20. The mechanism by which cholecystokinin peptides excite their target cells. Review.
    Petersen OH
    Biosci Rep; 1984 Apr; 4(4):275-83. PubMed ID: 6329351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.